DOI: 10.4244/EIJV8I5A97

Site of paravalvular leak after mitral valve replacement influences leaflet blockage by Amplatzer device

Nawwar Al-Attar1*, PhD, FRCS, FETCS; Ghada Al-Salih², MD, MSc; Soleiman Alkhoder1, MD; Costin Radu1, MD; Richard Raffoul1, MD; Patrick Nataf1, MD

Transcatheter closure of paravalvular or paraprosthetic leaks (PVL) is an alternative repair strategy to surgery in patients with isolated PVL, or at a very high risk of redo valve replacement.1 However, the occluder can lead to the dysfunction of valve leaflets of the mechanical valves. We studied the relationship of the anatomical location of PVL after mechanical mitral valve replacement on dysfunction of leaflets induced by the occluder after transcatheter closure. In a pig’s heart model, a St. Jude Medical® Masters bileaflet mitral valve (St. Jude Medical [SJM], St. Paul, MN, USA) was implanted using exactly the same technique as employed in humans. A gap was created and an Amplatzer occlusion device was surgically positioned to close the paravalvular gap. The mobility of the leaflets was examined according to different orientations of the mechanical prosthesis. The region of the pivots is elevated in the SJM prosthesis, which seems to confer protection by distancing the leaflets from the device which led to minimal interference (Figure 1) as compared to complete obstruction of the leaflet when the device was located at 90° from the site of pivots (Figure 2).

Figure 1. Amplatzer device is placed at the zone of the pivots of the mechanical valve. Minimal interference is observed.

Figure 2. Amplatzer device is placed at 90° from the zone of the pivots. Complete obstruction of the juxtapositional leaflet is observed by the occluder device.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 8 Number 5
Sep 28, 2012
Volume 8 Number 5
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-24-00010 Apr 15, 2024
Timing of revascularisation in acute coronary syndromes with multivessel disease – two sides of the same coin
Stähli B and Stehli J
free

Editorial

10.4244/EIJ-E-24-00016 Apr 15, 2024
Can artificial intelligence help Heart Teams make decisions?
Koch V
free

Editorial

10.4244/EIJ-E-24-00006 Apr 15, 2024
The miracle of left ventricular recovery after transcatheter aortic valve implantation
Dauerman H and Lahoud R
free

Original Research

10.4244/EIJ-D-23-00643 Apr 15, 2024
A study of ChatGPT in facilitating Heart Team decisions on severe aortic stenosis
Salihu A et al

State-of-the-Art

10.4244/EIJ-D-23-00836 Apr 15, 2024
Renal denervation in the management of hypertension
Lauder L et al
free
Trending articles
338.03

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
284.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved